Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjogren's syndrome in the JOQUER randomized trial

Iris Bodewes, JE Gottenberg, Corine Van Helden - Meeuwsen, X Mariette, Marjan Versnel

Research output: Contribution to journal › Article › Academic › peer-review

56 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	107-111
Number of pages	5
Journal	Rheumatology
Volume	59
Issue number	1
DOIs	https://doi.org/10.1093/rheumatology/kez242
Publication status	Published - 2020

Research programs

@article{7555ee466d994cbaac36951042b8683e,

title = "Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjogren's syndrome in the JOQUER randomized trial",

author = "Iris Bodewes and JE Gottenberg and {Van Helden - Meeuwsen}, Corine and X Mariette and Marjan Versnel",

year = "2020",

doi = "10.1093/rheumatology/kez242",

language = "Undefined/Unknown",

volume = "59",

pages = "107--111",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjogren's syndrome in the JOQUER randomized trial

AU - Bodewes, Iris

AU - Gottenberg, JE

AU - Van Helden - Meeuwsen, Corine

AU - Mariette, X

AU - Versnel, Marjan

PY - 2020

Y1 - 2020

U2 - 10.1093/rheumatology/kez242

DO - 10.1093/rheumatology/kez242

M3 - Article

C2 - 31237947

SN - 1462-0324

VL - 59

SP - 107

EP - 111

JO - Rheumatology

JF - Rheumatology

IS - 1

ER -